Home > Insider Trading > Filing (0000899243-20-028016)

Filing Details

Accession Number:: 0000899243-20-028016
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-13 16:59:52
Reporting Period:: 2020-10-06

Accepted Time:: 2020-10-13 16:59:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1791091	Healthcare Merger Corp.	HCCO	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1453072	Alyeska Investment Group, L.p.	77 West Wacker Drive, 7Th Floor Chicago IL 60601	No	No	Yes	No
1456506	Alyeska Master Fund, L.p.	77 West Wacker Drive, 7Th Floor Chicago IL 60601	No	No	Yes	No
1775953	Alyeska Master Fund 3, L.p.	77 West Wacker Drive, 7Th Floor Chicago IL 60601	No	No	Yes	No
1822280	Anand Parekh	77 West Wacker Drive, 7Th Floor Chicago IL 60601	No	No	Yes	No
1822281	Alyeska Investments, Llc	77 West Wacker Drive, 7Th Floor Chicago IL 60601	No	No	Yes	No
1822286	Alyeska Investment Group, Llc	77 West Wacker Drive, 7Th Floor Chicago IL 60601	No	No	Yes	No
1822287	Alyeska Fund Gp, Llc	77 West Wacker Drive, 7Th Floor Chicago IL 60601	No	No	Yes	No
1822509	Alyeska Fund 3 Gp, Llc	77 West Wacker Drive, 7Th Floor Chicago IL 60601	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2020-10-06	98,381	$10.04	2,768,555	No	4	P	Direct
Class A Common Stock	Acquisiton	2020-10-06	97,599	$10.04	2,746,579	No	4	P	Direct
Class A Common Stock	Acquisiton	2020-10-06	782	$10.04	21,976	No	4	P	Direct
Class A Common Stock	Acquisiton	2020-10-06	97,599	$10.04	2,746,579	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	782	$10.04	21,976	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	98,381	$10.04	2,768,555	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	98,381	$10.04	2,768,555	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	98,381	$10.04	2,768,555	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	169,603	$10.05	2,938,158	No	4	P	Direct
Class A Common Stock	Acquisiton	2020-10-06	168,258	$10.05	2,914,837	No	4	P	Direct
Class A Common Stock	Acquisiton	2020-10-06	1,345	$10.05	23,321	No	4	P	Direct
Class A Common Stock	Acquisiton	2020-10-06	168,258	$10.05	2,914,837	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	1,345	$10.05	23,321	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	169,603	$10.05	2,938,158	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	169,603	$10.05	2,938,158	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	169,603	$10.05	2,938,158	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	61,842	$10.06	3,000,000	No	4	P	Direct
Class A Common Stock	Acquisiton	2020-10-06	61,351	$10.06	2,976,188	No	4	P	Direct
Class A Common Stock	Acquisiton	2020-10-06	491	$10.06	23,812	No	4	P	Direct
Class A Common Stock	Acquisiton	2020-10-06	61,351	$10.06	2,976,188	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	491	$10.06	23,812	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	61,842	$10.06	3,000,000	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	61,842	$10.06	3,000,000	No	4	P	Indirect	Footnotes
Class A Common Stock	Acquisiton	2020-10-06	61,842	$10.06	3,000,000	No	4	P	Indirect	Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes
No	4	P	Indirect	Footnotes

Footnotes

Alyeska Investment Group, L.P. (the "Investment Manager") is the investment manager of each of Alyeska Master Fund, L.P. ("Fund 1") and Alyeska Master Fund 3, L.P. ("Fund 3" and, together with Fund 1, the "Funds"). In that capacity, the Investment Manager directs the voting and disposition of securities held by the Funds. Fund 1 is the direct owner of 2,976,188 shares of Class A Common Stock, par value $0.0001 per share ("Shares"), of Healthcare Merger Corp. Fund 3 is the direct owner of 23,812 Shares. The Investment Manager receives an asset-based fee relating to the Shares directly held by the Funds, and does not hold a pecuniary interest in such Shares.
(i) Alyeska Fund GP, LLC is the general partner of Fund 1 and has an indirect profits interest in the Shares directly held by Fund 1; (ii) Alyeska Fund 3 GP, LLC is the general partner of Fund 3 and has an indirect profits interest in the Shares directly held by Fund 3; (iii) Alyeska Investment Group, LLC is the sole owner of Alyeska Fund GP, LLC and Alyeska Fund 3 GP, LLC, and has an indirect profits interest in the Shares directly held by the Funds; (iv) Alyeska Investments, LLC (together with Alyeska Fund GP, LLC, Alyeska Fund 3 GP, LLC and Alyeska Investment Group, LLC, the "Upper Tier Entities") is the managing member of Alyeska Investment Group, LLC and has an indirect profits interest in the Shares directly held by the Funds; and (v) Anand Parekh is the managing member of Alyeska Investments, LLC and has an indirect profits interest in the Shares directly held by the Funds.
The filing of this Form 4 shall not be construed as an admission that Mr. Parekh or any Upper Tier Entity is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any Shares. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, each of Mr. Parekh and the Upper Tier Entities disclaims such beneficial ownership, except to the extent of his or its pecuniary interest.
On October 6, 2020, (i) Fund 1 purchased 97,599, 168,258 and 61,351 Shares for $10.04, $10.05 and $10.06 per Share, respectively, and (ii) Fund 3 purchased 782, 1,345 and 491 Shares for $10.04, $10.05 and $10.06 per Share, respectively.
The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16(a)-3(j) under the Exchange Act.